S. Mukaddamdaher et al., CLONIDINE AND ST-91 MAY ACTIVATE IMIDAZOLINE BINDING-SITES IN THE HEART TO RELEASE ATRIAL-NATRIURETIC-PEPTIDE, Hypertension, 30(1), 1997, pp. 83-87
It is well established that the antihypertensive drug clonidine acts t
hrough specific imidazoline receptors in the brain and kidney to incre
ase diuresis, natriuresis, acid kaliuresis. We have previously shown t
hat the effects of clonidine are associated with elevated plasma atria
l natriuretic peptide (ANP). Similar to clonidine, ST-91, a clonidine
analogue that does not cross the blood-brain barrier, evokes renal res
ponses that are also associated with elevated plasma ANP. The mechanis
ms of ANP increase elicited by these imidazoline drugs are unclear. Si
nce ANP is primarily released from the cardiac atria, we investigated
the direct effect of the imidazoline drugs on ANP release by incubatin
g left and right atrial sections with 10(-6) mom ST-91 in the presence
and absence of efaroxan, a selective imidazoline I-1 receptor antagon
ist, for 30 minutes at 37 degrees C. ST-91 significantly stimulated AN
P release, and the effect was inhibited by 10(-6) mol/L efaroxan. Furt
her studies using heart perfusion with the imidazoline drugs with and
without antagonists over 30 minutes revealed that both clonidine and S
T-91 gradually stimulated ANP release. Also, perfusion with these comp
ounds resulted in a gradual decrease in heart rate, but bradycardia wa
s significant only with clonidine. The effects of ST-91 were inhibited
by 10(-6) mol/L efaroxan and to a lesser extent by 10(-6) mol/L yohim
bine, implying that the actions of ST-91 were mainly mediated by I-1 r
eceptors. On the other hand, the actions of clonidine were inhibited b
y 10(-5) mol/L efaroxan and by 10(-6) mol/L yohimbine, an alpha(2)-adr
enoceptor antagonist, which may suggest that the actions of clonidine
were preferentially mediated by alpha(2)-adrenoceptors in the heart. T
hese results indicate that the peripheral actions of clonidine are pro
bably mediated by alpha(2) and imidazoline receptors and may involve d
irect stimulation of ANP release by the cardiac atria-an effect that m
ay account for the increase in plasma ANP levels and diuresis and natr
iuresis observed in vivo after administration of clonidine and its ana
logues.